Thursday - October 24, 2024
The 2024 Impact Report of the Cancer Research Institute
August 10, 2024
NEW YORK, Aug. 10 (TNSres) -- Cancer Research Institute issued the following news:

Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront of advancing immunotherapy, fundamentally reshaping cancer treatment, and establishing immunotherapy as the fourth pillar of cancer care.

Thanks to CRI's 71 years of dedication, 45 percent of all newly diagnosed cancer patients are eligible for at least one form of immunotherapy today.

. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products